Health Cor Management, L.P. Natera, Inc. Transaction History

Health Cor Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$36.93 - $56.68 $30.8 Million - $47.2 Million	-833,290 Reduced 92.75%	65,130 $2.85 Million
Q2 2022 Aug 15, 2022	SELL	$28.13 - $44.54 $15.5 Million - $24.5 Million	-551,116 Reduced 38.02%	898,420 $31.8 Million
Q1 2022 May 16, 2022	BUY	$30.32 - $91.33 $21.1 Million - $63.6 Million	696,616 Added 92.52%	1,449,536 $59 Million
Q4 2021 Feb 14, 2022	SELL	$86.26 - $119.0 $12.5 Million - $17.2 Million	-144,726 Reduced 16.12%	752,920 $70.3 Million
Q3 2021 Nov 15, 2021	BUY	$100.17 - $126.36 $10.8 Million - $13.6 Million	107,988 Added 13.68%	897,646 $100 Million
Q2 2021 Aug 16, 2021	BUY	$86.05 - $119.72 $68 Million - $94.5 Million	789,658 New	789,658 $89.7 Million

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.